Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 101–200 of 1,000
Wu, H., Yang, H., Rhee, J., Zhang, J. Z., Lam, C. K., Sallam, K., Chang, A. C. Y., Ma, N., Lee, J., Zhang, H., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz326 · Cited by 139
Di Pasquale, E., Lodola, F., Miragoli, M., Denegri, M., Avelino-Cruz, J. E., Buonocore, M., Nakahama, H., Portararo, P., Bloise, R., Napolitano, C., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.369 · Cited by 129
Kernik, D. C., Morotti, S., Wu, H., Garg, P., Duff, H. J., Kurokawa, J., Jalife, J., Wu, J. C., Grandi, E., & Clancy, C. E. (2019) · The Journal of Physiology · doi:10.1113/jp277724 · Cited by 141
Ionta, V., Liang, W., Kim, E. H., Rafie, R., Giacomello, A., Marbán, E., & Cho, H. C. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.11.004 · Cited by 128
Shinnawi, R., Huber, I., Maizels, L., Shaheen, N., Gepstein, A., Arbel, G., Tijsen, A. J., & Gepstein, L. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.08.009 · Cited by 137
Self-citationInduced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
Panicker, L. M., Miller, D., Park, T. S., Patel, B., Azevedo, J. L., Awad, O., Masood, M. A., Veenstra, T. D., Goldin, E., Stubblefield, B. K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207889109 · Cited by 129
“hiPSC have been derived from patients affected by a variety of diseases (8–11), including long QT syndrome (12, 13), familial dysautonomia (14), and Alzheimer’s disease (15), and important aspects of the disease phenotype have been recapitulated in the relevant hiPSC-derived cell types (16).”
BackgroundMalan, D., Friedrichs, S., Fleischmann, B. K., & Sasse, P. (2011) · Circulation Research · doi:10.1161/circresaha.111.243139 · Cited by 129
Sabapathy, V., & Kumar, S. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12839 · Cited by 123
Induced Pluripotent Stem Cells and Their Potential for Basic and Clinical Sciences
Ye, L., Swingen, C., & Zhang, J. J. (2013) · Current Cardiology Reviews · doi:10.2174/157340313805076278 · Cited by 168
Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery
Mercola, M., Colas, A., & Willems, E. (2013) · Circulation Research · doi:10.1161/circresaha.111.250266 · Cited by 122
Davis, R. P., van den Berg, C. W., Casini, S., Braam, S. R., & Mummery, C. L. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.001 · Cited by 134
Amano, Y., Nishiguchi, A., Matsusaki, M., Iseoka, H., Miyagawa, S., Sawa, Y., Seo, M., Yamaguchi, T., & Akashi, M. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.01.033 · Cited by 133
Modeling Supravalvular Aortic Stenosis Syndrome With Human Induced Pluripotent Stem Cells
Ge, X., Ren, Y., Bartulos, O., Lee, M. Y., Yue, Z., Kim, K.-Y., Li, W., Amos, P. J., Bozkulak, E. C., Iyer, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.116996 · Cited by 122
Sala, L., Bellin, M., & Mummery, C. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13577 · Cited by 121
Lin, B., Li, Y., Han, L., Kaplan, A. D., Ao, Y., Kalra, S., Bett, G. C. L., Rasmusson, R. L., Denning, C., & Yang, L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019505 · Cited by 116
Spencer, C. I., Baba, S., Nakamura, K., Hua, E. A., Sears, M. A. F., Fu, C.-C., Zhang, J., Balijepalli, S., Tomoda, K., Hayashi, Y., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.06.003 · Cited by 120
Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Boutique Science or Valuable Arrhythmia Model?
Knollmann, B. C. (2013) · Circulation Research · doi:10.1161/circresaha.112.300567 · Cited by 118
Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics
Chiamvimonvat, N., Chen‐Izu, Y., Clancy, C. E., Deschênes, I., Dobrev, D., Heijman, J., Izu, L. T., Qu, Z., Ripplinger, C. M., Vandenberg, J. I., et al. (2016) · The Journal of Physiology · doi:10.1113/jp272883 · Cited by 130
Farra, N., Zhang, W.-B., Pasceri, P., Eubanks, J. H., Salter, M. W., & Ellis, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.180 · Cited by 118
Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
El‐Battrawy, I., Lan, H., Cyganek, L., Zhao, Z., Li, X., Buljubasic, F., Lang, S., Yücel, G., Sattler, K., Zimmermann, W., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007394 · Cited by 124
Garg, P., Garg, V., Shrestha, R., Sanguinetti, M. C., Kamp, T. J., & Wu, J. C. (2018) · Circulation Research · doi:10.1161/circresaha.118.311209 · Cited by 131
Bett, G. C. L., Kaplan, A. D., Lis, A., Cimato, T. R., Tzanakakis, E. S., Zhou, Q., Morales, M. J., & Rasmusson, R. L. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.09.061 · Cited by 123
Magdy, T., Schuldt, A. J. T., Wu, J. C., Bernstein, D., & Burridge, P. W. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-053110 · Cited by 109
Three-dimensional filamentous human diseased cardiac tissue model
Ma, Z., Koo, S., Finnegan, M. A., Loskill, P., Huebsch, N., Marks, N. C., Conklin, B. R., Grigoropoulos, C. P., & Healy, K. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.052 · Cited by 113
Zhang, X.-H., Haviland, S., Wei, H., Šarić, T., Fatima, A., Hescheler, J., Cleemann, L., & Morad, M. (2013) · Cell Calcium · doi:10.1016/j.ceca.2013.04.004 · Cited by 108
Murine Electrophysiological Models of Cardiac Arrhythmogenesis
Huang, C. L.-H. (2016) · Physiological Reviews · doi:10.1152/physrev.00007.2016 · Cited by 113
Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration
Kaiser, N. J., & Coulombe, K. L. K. (2015) · Biomedical Materials · doi:10.1088/1748-6041/10/3/034003 · Cited by 107
Jang, J., Yoo, J.-E., Lee, J., Lee, D. R., Kim, J. Y., Huh, Y. J., Kim, D., Park, C., Hwang, D., Kim, H.-S., et al. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.3.015 · Cited by 120
Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes
Mehta, A., Sequiera, G. L., Ramachandra, C. J. A., Sudibyo, Y., Chung, Y., Sheng, J., Wong, K. Y., Tan, T. H., Wong, P., Liew, R., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu060 · Cited by 110
“Disease-specific-induced pluripotent stem cells offer unique opportunity for disease modelling.(10,11) Such models yield previously unavailable insights into the molecular basis of disease manifestations that could serve as an invaluable platform for risk stratification and drug discovery.”
BackgroundFunctional Cardiac Tissue Engineering
Liau, B., Zhang, D., & Bursac, N. (2012) · Regenerative Medicine · doi:10.2217/rme.11.122 · Cited by 105
Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells
Kim, J. J., Yang, L., Lin, B., Zhu, X., Sun, B., Kaplan, A. D., Bett, G. C. L., Rasmusson, R. L., London, B., & Salama, G. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.013 · Cited by 108
Du, D. T. M., Hellen, N., Kane, C., & Terracciano, C. M. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2014.11.008 · Cited by 109
Min, S., Kim, S., Sim, W., Choi, Y. S., Joo, H., Park, J.-H., Lee, S.-J., Kim, H., Lee, M. J., Jeong, I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46928-y · Cited by 125
Molecular pathogenesis of long QT syndrome type 2
Smith, J. L., Anderson, C. L., Burgess, D. E., Elayi, C. S., January, C. T., & Delisle, B. P. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2015.11.009 · Cited by 115
Pharmacogenomics of adverse drug reactions
Daly, A. K. (2013) · Genome Medicine · doi:10.1186/gm409 · Cited by 121
Vaidyanathan, R., Markandeya, Y. S., Kamp, T. J., Makielski, J. C., January, C. T., & Eckhardt, L. L. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00481.2015 · Cited by 104
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
Current insights into renal ciliopathies: what can genetics teach us?
Arts, H. H., & Knoers, N. V. A. M. (2013) · Pediatric Nephrology · doi:10.1007/s00467-012-2259-9 · Cited by 103
Current status of drug screening and disease modelling in human pluripotent stem cells
Rajamohan, D., Matsa, E., Kalra, S., Crutchley, J., Patel, A., George, V., & Denning, C. (2013) · BioEssays · doi:10.1002/bies.201200053 · Cited by 99
Ma, D., Wei, H., Lu, J., Huang, D., Liu, Z., Loh, L. J., Islam, O., Liew, R., Shim, W., & Cook, S. A. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0027-z · Cited by 96
Horváth, A., Lemoine, M. D., Löser, A., Mannhardt, I., Flenner, F., Uzun, A. U., Neuber, C., Breckwoldt, K., Hansen, A., Girdauskas, E., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.01.012 · Cited by 101
Wang, Y., Zhang, W. Y., Hu, S., Lan, F., Lee, A. S., Huber, B., Lisowski, L., Liang, P., Huang, M., de Almeida, P. E., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.274969 · Cited by 101
Lemoine, M. D., Krause, T., Koivumäki, J. T., Prondzynski, M., Schulze, M. L., Girdauskas, E., Willems, S., Hansen, A., Eschenhagen, T., & Christ, T. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.006035 · Cited by 106
Cellular and Engineered Organoids for Cardiovascular Models
Thomas, D., Choi, S., Alamana, C., Parker, K. K., & Wu, J. C. (2022) · Circulation Research · doi:10.1161/circresaha.122.320305 · Cited by 105
Stillitano, F., Hansen, J., Kong, C., Karakikes, I., Funck‐Brentano, C., Geng, L., Scott, S. A., Reynier, S., Ma, W., Valogne, Y., et al. (2017) · eLife · doi:10.7554/elife.19406 · Cited by 99
Kussauer, S., David, R., & Lemcke, H. (2019) · Cells · doi:10.3390/cells8111331 · Cited by 101
Magdy, T., Jouni, M., Kuo, H., Weddle, C. J., Lyra‐Leite, D. M., Fonoudi, H., Romero‐Tejeda, M., Gharib, M., Javed, H., Fajardo, G., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055801 · Cited by 104
Churko, J. M., Burridge, P. W., & Wu, J. C. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-511-8_7 · Cited by 94
Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing
Sinnecker, D., Laugwitz, K., & Moretti, A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.004 · Cited by 101
Leyton-Mange, J. S., Mills, R. W., Macri, V., Jang, M. Y., Butte, F. N., Ellinor, P. T., & Milan, D. J. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.01.003 · Cited by 103
Two decades of embryonic stem cells: a historical overview
Eguizabal, C., Aran, B., Chuva de Sousa Lopes, S. M., Geens, M., Heindryckx, B., Panula, S., Popovic, M., Vassena, R., & Veiga, A. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoy024 · Cited by 91
hERG 1b is critical for human cardiac repolarization
Jones, D. K., Liu, F., Vaidyanathan, R., Eckhardt, L. L., Trudeau, M. C., & Robertson, G. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414945111 · Cited by 96
Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes
Eschenhagen, T., Mummery, C., & Knollmann, B. C. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv017 · Cited by 97
Jonsson, M. K. B., Wang, Q.-D., & Becker, B. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2011.0396 · Cited by 94
Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies
Brandão, K. O., Tabel, V. A., Atsma, D. E., Mummery, C. L., & Davis, R. P. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030320 · Cited by 106
New lessons learned from disease modeling with induced pluripotent stem cells
Önder, T. T., & Daley, G. Q. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.05.005 · Cited by 97
Andrysiak, K., Stępniewski, J., & Dulak, J. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02536-z · Cited by 103
Clinical and Genetic Determinants of Torsade de Pointes Risk
Sauer, A. J., & Newton‐Cheh, C. (2012) · Circulation · doi:10.1161/circulationaha.111.080887 · Cited by 98
Mehta, A. K., Chung, Y. Y., Ng, A., Iskandar, F., Atan, S., Wei, H., Dusting, G. J., Sun, W. Y., Wong, P., & SHIM, W. S. N. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr132 · Cited by 95
Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction
Malan, D., Zhang, M., Stallmeyer, B., Müller, J., Fleischmann, B. K., Schulze-Bahr, E., Sasse, P., & Greber, B. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0530-0 · Cited by 91
Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures
Sacchetto, C., Vitiello, L., de Windt, L. J., Rampazzo, A., & Calore, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093404 · Cited by 91
Pluripotent Stem Cell Models of Human Heart Disease
Moretti, A., Laugwitz, K.-L., Dorn, T., Sinnecker, D., & Mummery, C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014027 · Cited by 91
Shinnawi, R., Shaheen, N., Huber, I., Shiti, A., Arbel, G., Gepstein, A., Ballan, N., Setter, N., Tijsen, A. J., Borggrefe, M. M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.055 · Cited by 92
Self-citationLi, Z., & Rana, T. M. (2012) · Nature Communications · doi:10.1038/ncomms2059 · Cited by 97
Oikonomopoulos, A., Kitani, T., & Wu, J. C. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.026 · Cited by 95
Three-dimensional cardiac tissue fabrication based on cell sheet technology
Masuda, S., & Shimizu, T. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.002 · Cited by 92
Parrotta, E. I., Lucchino, V., Scaramuzzino, L., Scalise, S., & Cuda, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124354 · Cited by 88
van den Heuvel, N. H. L., van Veen, T. A. B., Lim, B., & Jonsson, M. K. B. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.011 · Cited by 93
High-purity enrichment of functional cardiovascular cells from human iPS cells
Lin, B., Kim, J. K., Li, Y., Pan, H., Carvajal‐Vergara, X., Salama, G., Cheng, T., Li, Y., Lo, C. W. Y., & Yang, L. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs185 · Cited by 90
Fendyur, A., & Spira, M. E. (2012) · Frontiers in Neuroengineering · doi:10.3389/fneng.2012.00021 · Cited by 88
Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine
Hamazaki, T., Rouby, N. M. E., Fredette, N. C., Santostefano, K. E., & Terada, N. (2017) · Stem Cells · doi:10.1002/stem.2570 · Cited by 95
Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?
Magdy, T., Burmeister, B. T., & Burridge, P. W. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.009 · Cited by 89
Veerman, C. C., Mengarelli, I., Lodder, E. M., Kosmidis, G., Bellin, M., Zhang, M., Dittmann, S., Guan, K., Wilde, A. A. M., Schulze‐Bahr, E., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005135 · Cited by 86
Kadota, S., Minami, I., Morone, N., Heuser, J. E., Agladze, K., & Nakatsuji, N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs418 · Cited by 82
Examining the Paracrine Effects of Exosomes in Cardiovascular Disease and Repair
Gartz, M., & Strande, J. L. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007954 · Cited by 87
Zhuang, R. Z., Lock, R., Liu, B., & Vunjak-Novakovic, G. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00885-3 · Cited by 84
Fatima, A., Kaifeng, S., Dittmann, S., Xu, G., Gupta, M. K., Linke, M., Zechner, U., Nguemo, F., Milting, H., Farr, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083005 · Cited by 83
Adapting human pluripotent stem cells to high-throughput and high-content screening
Desbordes, S. C., & Studer, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.139 · Cited by 93
Eschenhagen, T., & Carrier, L. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2214-0 · Cited by 86
Human iPSC modeling of heart disease for drug development
Hnatiuk, A. P., Briganti, F., Staudt, D., & Mercola, M. A. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.016 · Cited by 82
Honda, M., Kiyokawa, J., Tabo, M., & Inoue, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11038fp · Cited by 89
Jouni, M., Si‐Tayeb, K., Es‐Salah‐Lamoureux, Z., Latypova, X., Champon, B., Caillaud, A., Rungoat, A., Charpentier, F., Loussouarn, G., Baró, I., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002159 · Cited by 74
Zhao, Z., Lan, H., El‐Battrawy, I., Li, X., Buljubasic, F., Sattler, K., Yücel, G., Lang, S., Tiburcy, M., Zimmermann, W., et al. (2018) · Stem Cells International · doi:10.1155/2018/6067096 · Cited by 87
Scheel, O., Frech, S., Amuzescu, B., Eisfeld, J., Lin, K.-H., & Knott, T. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2014.601 · Cited by 78
Concise Review: Drug Discovery in the Age of the Induced Pluripotent Stem Cell
Ko, H. C., & Gelb, B. D. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0162 · Cited by 80
Lorberbaum, T., Sampson, K. J., Chang, J. B., Iyer, V., Woosley, R. L., Kass, R. S., & Tatonetti, N. P. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.761 · Cited by 78
Burnett, S. D., Blanchette, A. D., Chiu, W. A., & Rusyn, I. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1894122 · Cited by 117
High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells
D'Antonio, M., Woodruff, G., Nathanson, J. L., D'Antonio-Chronowska, A., Arias, A., Matsui, H., Williams, R., Herrera, C., Reyna, S. M., Yeo, G. W., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.011 · Cited by 77
Neural Lineage Differentiation From Pluripotent Stem Cells to Mimic Human Brain Tissues
Hong, Y. J., & Do, J. T. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00400 · Cited by 75
Lü, J., Wei, H., Wu, J., Jamil, M. F. A., Tan, M., Adenan, M. I., Wong, P., & SHIM, W. S. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115648 · Cited by 78
Zwi-Dantsis, L., Huber, I., Habib, M., Winterstern, A., Gepstein, A., Arbel, G., & Gepstein, L. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs096 · Cited by 78
Self-citationCasini, S., Verkerk, A. O., & Remme, C. A. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6735-0 · Cited by 83
Using human induced pluripotent stem cells to treat retinal disease
Borooah, S., Phillips, M. J., Bilican, B., Wright, A. F., Wilmut, I., Chandran, S., Gamm, D. M., & Dhillon, B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.09.002 · Cited by 81
Nakamura, Y., Matsuo, J., Miyamoto, N., Ojima, A., Ando, K., Kanda, Y., Sawada, K., Sugiyama, A., & Sekino, Y. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13248fp · Cited by 76
Shaheen, N., Shiti, A., Huber, I., Shinnawi, R., Arbel, G., Gepstein, A., Setter, N., Goldfracht, I., Gruber, A., Chorna, S. V., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.04.006 · Cited by 75
Self-citationDevalla, H. D., & Passier, R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5457 · Cited by 75
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement
Bartlett, S. T., Markmann, J. F., Johnson, P., Korsgren, O., Hering, B. J., Scharp, D., Kay, T. W. H., Bromberg, J., Odorico, J. S., Weir, G. C., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001055 · Cited by 75
CRISPR/Cas9‐Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells
Sharma, A., Toepfer, C. N., Ward, T. L., Wasson, L. K., Agarwal, R., Conner, D. A., Hu, J. H., & Seidman, C. E. (2018) · Current Protocols in Human Genetics · doi:10.1002/cphg.52 · Cited by 82
Sallam, K., Li, Y., Sager, P. T., Houser, S. R., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.116.304494 · Cited by 74
Nogueira, D. E. S., Rodrigues, C. A. V., Carvalho, M. S., Miranda, C. C., Hashimura, Y., Jung, S., Lee, B., & Cabral, J. M. S. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0204-1 · Cited by 75
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.